Gene-Editing Biotech Says Rivals Infringed CRISPR Patent
A Korean biotech company has accused several companies of infringing its CRISPR gene-editing patent in the U.K., telling a London court that they must enter a license to use the technology....To view the full article, register now.
Already a subscriber? Click here to view full article